Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $303.3K | $778.0K | $3.3M | $3.7M | $4.7M |
| Gross profit | $0 | −$303.3K | −$778.0K | −$3.3M | −$3.7M | −$4.7M |
| Gross margin | — | — | — | — | — | — |
| R&D | $4.8M | $9.1M | $22.6M | $42.2M | $57.3M | $67.6M |
| Operating income | −$6.9M | −$13.8M | −$33.7M | −$64.2M | −$78.4M | −$75.3M |
| EBITDA | −$6.7M | −$13.5M | −$33.0M | −$60.8M | −$67.3M | −$70.4M |
| Net income | −$6.9M | −$14.0M | −$33.2M | −$61.1M | −$71.2M | −$69.7M |
| Net margin | — | — | — | — | — | — |
| EPS (diluted) | -12.69 | -20.48 | -0.82 | -2.13 | -1.82 | -1.74 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $0 | $-1.22 | $-1.22–$-1.22 | 1 |
| 2027 | $0 | $-1.43 | $-1.43–$-1.43 | 1 |
| 2028 | $0 | $-1.68 | $-1.68–$-1.68 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds ACHL.
No tracked institution reports a position in ACHL as of their last filing.
No one on the platform has traded ACHL yet.
| $5M |
| — |
| RNTXRein Therapeutics Inc. | $1.04 | +7.08% | $29M | — |
| RPHMReneo Pharmaceuticals, Inc. | $18.20 | +952.02% | $61M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$AIFF Massive volume wait for accumulation to finish for the squeeze massive news 😍😍 Watching $AMD $TSLA $FLZH $ACHL
View on StockTwits ↗$IPSC is in similar situation as $ACHL. IPSC - Trading way under cash and tutes not giving any credit for their pipeline. If this drops any more …I demand this management to close doors and give money to shareholders which is likely north of $1 per share.
View on StockTwits ↗IVDA is the sleeper AI + drone play people will pretend they knew about later. With a tiny float and commercial-ready robotics, it could re-rate hard off any government, defense, or safety contract. Bottomed. Unloved. Loaded. $UBX $QH $SGH $ACHL $VYNE
View on StockTwits ↗$ACHL now that it’s delisted from Nasdaq, how do I sell my shares? Missed the delisting notice.
View on StockTwits ↗I found you an Overbought RSI (Relative Strength Index) on the daily chart of Achilles Therapeutics PLC ADR. Is that bullish or bearish? $ACHL #Achilles #RsiOverbought #NASDAQ
View on StockTwits ↗Top Gainers PT2 $ZONE $PLTR $FLXS $ACON $ACHL Details: https://topstockalerts.com/market-gainers-and-losers/
View on StockTwits ↗Top Gainers PT2 $ZONE $PLTR $FLXS $ACON $ACHL Details: https://topstockalerts.com/market-gainers-and-losers/
View on StockTwits ↗$ACHL They have around 2$/share to distribute. Quarterly burn approx. 20m$ (before cut of workforce) and they got 12.4m for R&D and 12m from Astra. OS approx. 41m. Good Deal and it's much better than positive trial data
View on StockTwits ↗Morning Movers $ACHL $AMOD $EVAX $QNTM $EMPD
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.